Pulmonology

Papers
(The H4-Index of Pulmonology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up64
Reproducibility, validity, and reliability of the incremental step test for subjects with moderate to severe asthma59
Intra- and interobserver agreement of inspiratory capacity during cardio pulmonary exercise test42
Exposed posters40
Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis40
Mixed squamous cell and glandular papilloma of the bronchus39
Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries34
“ Gallia est omnis divisa in partes tres ”: Is it time to divide Pleuroparenchymal Fibroelastosis in three different forms?32
High-dose inhaled NO for the prevention of nosocomial pneumonia after cardiac surgery under cardiopulmonary bypass: A proof-of-concept prospective randomised study31
Intensity of exercise in people with COPD enrolled in community-based physical activities31
The Vacinómetro® initiative: an eleven-year monitorization of influenza vaccination coverage rates among risk groups in Portugal30
Smoking exposure trajectories and pulmonary function in early adulthood in a Brazilian cohort29
Chylothorax as an unusual presentation of Bosutinib therapy toxicity28
Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib28
Ultrasound-guided needle aspiration biopsy of isolated anterior mediastinal masses28
The public health impact of e-cigarette use: Revisiting Geoffrey Rose's prevention strategies27
Prevascular mediastinal angyomiolipoma. A case report26
What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 202326
Differences in exercise capacity and health-related quality of life according to the body mass index in patients with COPD25
Diaphragm thickening fraction and inspiratory effort in patients with SARS-COV II pneumonia receiving different non-invasive respiratory supports24
Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohort24
Prescribing and adjusting exercise training in chronic respiratory diseases – Expert-based practical recommendations24
Effects of asymmetric nasal high-flow cannula on carbon dioxide in hypercapnic patients: A randomised crossover physiological pilot study23
0.099826097488403